A black hole found just 1,000 light-years from Earth is the closest yet found to our planet.
Why it matters: The relatively nearby black hole — which is orbited by two stars — presents scientists with the opportunity to learn more about these mysterious objects by studying one not too far from our own part of the galaxy.
NASA and Tom Cruise are in talks to shoot a movie onboard the International Space Station, the space agency's administrator Jim Bridenstine confirmed in a tweet Tuesday.
Why it matters: NASA has been looking for new ways to try to commercialize the space station, and filming a movie on location in orbit could be one way to do just that.
As the coronavirus rages, NASA is making strides toward its ambitious goal to launch astronauts to the surface of the Moon in the next four years.
The big picture: NASA's 2024 Artemis Moon mission is the Trump administration's tentpole civil space policy expected to challenge geopolitical rivals like China for supremacy in space.
The Sun might be a bit more quiet than other stars of its kind, a feature that potentially makes our planet more friendly to life, according to a new study.
Why it matters: Understanding the Sun in context with other stars being studied today is important to learn more about the history of how our solar system came to be and just how uncommon — or common — life is in the universe.
The economic downturn caused by the coronavirus pandemic will likely make the U.S. space industry even more focused on government money and funding —and potentially set back advancements toward commercializing the industry.
Why it matters: For over 10 years, the space industry has been making strides to diversify its base of customers away from just government entities to more commercial customers and industries.
This pandemic may be caused by a virus, but desperate measures to save patients often include overprescribing antibiotics, which is raising concerns about furthering antibiotic resistance.
Why it matters: Antimicrobial resistance (AMR) forces clinicians to look for other drugs to treat patients but the antibiotic pipeline is in dire straits. The COVID-19 pandemic is exposing how few options there are and the need for investment to be prepared for more antibiotic resistant infections to emerge, industry experts tell Axios.